Letter to the Editors of Substance Abuse: vaping and youths researches

According to prof. Riccardo Polosa, CoEHAR founder: "This small qualitative research simply found what we already knew: that young people are eager to explore new experiences, with vaping potentially being one of them. A critical limitation of this research is the absence of insights into how these participants have been educated about the health implications and addictive nature of nicotine/vaping. To work towards a smoke-free world, it's essential that our messaging on vaping's risk-to-benefit ratio is both accurate and truthful"

Continue ReadingLetter to the Editors of Substance Abuse: vaping and youths researches

Covid-19: ecig only add 1% of risk compared to breathing

Incredibly, people close to an infected vaper using an e-cigarette in home or restaurant scenarios face a one percent increase of risk of contagion compared to the control case of a normal breathing (without vaping) inside closed spaces. This relative added risk becomes 5-17 percent for high intensity vaping and up to 260 percent for speaking for various periods and coughing.

Continue ReadingCovid-19: ecig only add 1% of risk compared to breathing

CoEHAR and ANPVU to Commissioner Kyriakides: ecig as aids for smoking cessation

Prof. Riccardo Polosa, Founder of the CoEHAR, and Carmine Canino, President of  ANPVU, National Association of ecig consumers, have sent a letter to the European Commissioner for Health Stella Kyriakides, regarding her statements on the effectiveness of e-cigarettes to quit smoking.

Continue ReadingCoEHAR and ANPVU to Commissioner Kyriakides: ecig as aids for smoking cessation
Read more about the article Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project
alfio distefano experimental biology

Experimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project

CoEHAR presented the results of the Replica project during Experimental Biology 2022, the annual meeting that brings together thousands of scientists and experts in the field of anatomy, biochemistry and molecular biology, investigative pathology, pharmacology, and physiology. Representing CoEHAR, the researcher Alfio Distefano, PhD student in neuroscience at the University of Catania

Continue ReadingExperimental Biology 2022: CoEHAR flies to Philadelphia to present the Replica project